Opinion
Video
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Brukinsa May Improve Efficacy Versus Imbruvica in R/R CLL and SLL
The Treatment Journey of a Patient with CLL
Learning to ‘Let it Be’ After Poor Test Results
Preparing for Treatment: A Personal Reflection on Cancer